Treatment Access Issues Dominate HIV/Viral Hepatitis Co-infection Meeting
Treatment access issues related to hepatitis C virus (HCV) infection and HIV-HCV co-infection dominated much...
Learn MoreTreatment access issues related to hepatitis C virus (HCV) infection and HIV-HCV co-infection dominated much...
Learn MoreOn Friday, July 17 and Saturday, July 18 the 2nd International HIV/Viral Hepatitis Co-Infection Meeting brought together...
Learn MoreIn 1993 the formation of a community advisory committee was groundbreaking. Over the past 25...
Learn MoreFor the last 25 years the CTN has played a central role in driving Canada’s...
Learn MoreThe results of Phase I of the ANRS IPERGAY trial (CTN 268) are very promising,...
Learn MoreThe TriiAdd study (CTN 286) will test to see if using a new single tablet...
Learn MoreEarly data from the CTN 268 – ANRS IPERGAY trial validates ‘on demand’ pre-exposure prophylaxis...
Learn MoreCTN researchers part of global strategy to find a cure The CTN’s Vaccines and Immunotherapies...
Learn MoreCTN renewal by CIHR marks 29 years of uninterrupted funding A Prevention, treatments and a...
Learn MoreCTN investigators presenting their work at the XX International AIDS Conference (AIDS 2014, July 20-25)...
Learn MoreThe Canadian Association for HIV Research’s annual conference (CAHR 2014) will be held at the...
Learn More